HER2 in Oesophageal Squamous Cell Carcinoma
Author Information
Author(s): Metges J-P, Gibault L, Conan-Charlet V, Lozac'H P, Robaszkiewicz M, Bessaguet C, Lagarde N, Volant A
Primary Institution: Institute of Oncology, Morvan Hospital
Hypothesis
What is the potential impact of HER2 and other targets in oesophageal squamous cell carcinoma?
Conclusion
HER2 is a potentially interesting target in oesophageal neoplasms, but further investigations are needed to confirm these findings.
Supporting Evidence
- The study found that HER2 was overexpressed in only 2.8% of the tumours.
- The authors noted a consensus about the difficulty of comparing data on angiogenesis assessment.
- Further investigations are needed to confirm the potential interest of HER2 status.
Takeaway
The study looked at how a protein called HER2 might be important in a type of throat cancer, but they found it was only present in a small number of cases.
Methodology
The study used immunohistochemical data to assess HER2 and other targets in patients with oesophageal squamous cell carcinoma.
Potential Biases
Potential biases may arise from the heterogeneity in methodologies used across different studies.
Limitations
The study's findings may be limited by the methodologies used in other studies and the small percentage of HER2 overexpression observed.
Participant Demographics
Patients with oesophageal squamous cell carcinoma.
Statistical Information
P-Value
0.017
Statistical Significance
p=0.017
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website